Natixis’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,317
Closed -$421K 1215
2023
Q4
$421K Buy
+19,317
New +$421K ﹤0.01% 623